HIV SeropositivityHIV SeroprevalenceHIV InfectionsSubstance Abuse, IntravenousAntineoplastic Combined Chemotherapy ProtocolsTreatment OutcomeDisease-Free SurvivalSexual BehaviorRisk FactorsDisease ProgressionSeroepidemiologic StudiesAntibodies, ViralAntibodies, BacterialChlamydophila pneumoniaeImmunoglobulin GChlamydophila InfectionsEnzyme-Linked Immunosorbent AssaySerologic TestsPrevalenceHIV SeronegativityHelicobacter pyloriHelicobacter InfectionsProspective StudiesAcquired Immunodeficiency SyndromeTime FactorsHIV-1ToxocariasisFollow-Up StudiesCohort StudiesCase-Control StudiesCross-Sectional StudiesCytomegalovirus InfectionsAntibodies, ProtozoanRetrospective StudiesToxoplasmosisHepatitis CAge FactorsHerpesvirus 2, HumanToxocaraAIDS SerodiagnosisBlood DonorsCD4 Lymphocyte CountPrognosisPapillomavirus InfectionsNeosporaRural PopulationMultivariate AnalysisCytomegalovirusBrazilOdds RatioHerpes GenitalisImmunoglobulin AAnti-HIV AgentsSyphilisIncidenceViral LoadHuman papillomavirus 16HomosexualityCell CycleToxoplasmaSurvival AnalysisImmunoglobulin MHomosexuality, MaleBiological Markers